• Ortho RTI updates on clinical hold for drug trial

    Ortho Regenerative Technologies has submitted requested data related to its Ortho-R drug to the FDA after the company paused its clinical trial.
  • Vivex Biologics launches bone graft substitutes

    Vivex Biologics launched its Via Mend synthetic bone fillers, a line of bone graft substitutes, the company announced July 15.
  • Bioventus in 2021: 5 updates to know

    Since launching its initial public offering in February, orthobiologics company Bioventus marked several notable achievements, including a multimillion-dollar acquisition.

Featured Webinars

Featured Whitepapers